Regulation of GATA4 Transcriptional Activity in Cardiovascular Development and Disease

Current Topics in Developmental Biology

Volumn 100, Issue , 2012, Pages 143-169

  Zhou, Pingzhu ^a   He, Aibin ^b   Pu, William T ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

Chromatin structure; Heart development; Transcriptional regulation

Indexed keywords

EID: 84858785411     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387786-4.00005-1     Document Type: Chapter

References (127)

1. Arceci R.J., King A.A., Simon M.C., Orkin S.H., Wilson D.B. Mouse GATA-4: A retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol. Cell Biol. 1993, 13:2235-2246.
2. Bates D.L., Chen Y., Kim G., Guo L., Chen L. Crystal structures of multiple GATA zinc fingers bound to DNA reveal new insights into DNA recognition and self-association by GATA. J. Mol. Biol. 2008, 381:1292-1306.
3. Belaguli N.S., Sepulveda J.L., Nigam V., Charron F., Nemer M., Schwartz R.J. Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators. Mol. Cell Biol. 2000, 20:7550-7558.
4. Berger M.F., Philippakis A.A., Qureshi A.M., He F.S., Estep P.W.r., Bulyk M.L. Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities. Nat. Biotechnol. 2006, 24:1429-1435.
5. Bielinska M., Jay P.Y., Erlich J.M., Mannisto S., Urban Z., Heikinheimo M., Wilson D.B. Molecular genetics of congenital diaphragmatic defects. Ann. Med. 2007, 39:261-274.
6. Bisping E., Ikeda S., Kong S.W., Tarnavski O., Bodyak N., McMullen J.R., Rajagopal S., Son J.K., Ma Q., Springer Z., Kang P.M., Izumo S., et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:14471-14476.
7. Black B.L. Transcriptional pathways in second heart field development. Semin. Cell Dev. Biol. 2007, 18:67-76.
8. Blow M.J., McCulley D.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F., Afzal V., Bristow J., et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 2010, 42(9):806-810.
9. Boyes J., Byfield P., Nakatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 1998, 396:594-598.
10. Bresnick E.H., Lee H.Y., Fujiwara T., Johnson K.D., Keles S. GATA switches as developmental drivers. J. Biol. Chem. 2010, 285:31087-31093.
11. Bruneau B.G. The developmental genetics of congenital heart disease. Nature 2008, 451:943-948.
12. Butler T.L., Esposito G., Blue G.M., Cole A.D., Costa M.W., Waddell L.B., Walizada G., Sholler G.F., Kirk E.P., Feneley M., Harvey R.P., Winlaw D.S. GATA4 mutations in 357 unrelated patients with congenital heart malformation. Genet. Test. Mol. Biomarkers 2010, 14:797-802.
13. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., Chen J.F., Deng Z., Gunn B., Shumate J., Willis M.S., Selzman C.H., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 2009, 119:2772-2786.
14. Charron F., Paradis P., Bronchain O., Nemer G., Nemer M. Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol. Cell. Biol. 1999, 19:4355-4365.
15. Charron F., Tsimiklis G., Arcand M., Robitaille L., Liang Q., Molkentin J.D., Meloche S., Nemer M. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev. 2001, 15:2702-2719.
16. Chen Y., Han Z.Q., Yan W.D., Tang C.Z., Xie J.Y., Chen H., Hu D.Y. A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect. J. Thorac. Cardiovasc. Surg. 2010, 140:684-687.
17. Chen Y., Mao J., Sun Y., Zhang Q., Cheng H.B., Yan W.H., Choy K.W., Li H. A novel mutation of GATA4 in a familial atrial septal defect. Clin. Chim. Acta 2010, 411:1741-1745.
18. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
19. Crispino J.D., Lodish M.B., Thurberg B.L., Litovsky S.H., Collins T., Molkentin J.D., Orkin S.H. Proper coronary vascular development and heart morphogenesis depend on interaction of GATA-4 with FOG cofactors. Genes Dev. 2001, 15:839-844.
20. Dai Y.S., Markham B.E. p300 Functions as a coactivator of transcription factor gata-4. J. Biol. Chem. 2001, 276:37178-37185.
21. Denslow S.A., Wade P.A. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007, 26:5433-5438.
22. Diedrichs H., Chi M., Boelck B., Mehlhorn U., Schwinger R.H. Increased regulatory activity of the calcineurin/NFAT pathway in human heart failure. Eur. J. Heart Fail. 2004, 6:3-9.
23. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
24. Durocher D., Charron F., Warren R., Schwartz R.J., Nemer M. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 1997, 16:5687-5696.
25. Evans T., Felsenfeld G. The erythroid-specific transcription factor Eryf1: A new finger protein. Cell 1989, 58:877-885.
26. Foley A.C., Gupta R.W., Guzzo R.M., Korol O., Mercola M. Embryonic heart induction. Ann. N. Y. Acad. Sci. 2006, 1080:85-96.
27. Fujiwara T., O'Geen H., Keles S., Blahnik K., Linnemann A.K., Kang Y.A., Choi K., Farnham P.J., Bresnick E.H. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 2009, 36:667-681.
28. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
29. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
30. Grepin C., Nemer G., Nemer M. Enhanced cardiogenesis in embryonic stem cells overexpressing the GATA-4 transcription factor. Development 1997, 124:2387-2395.
31. Hall J.L., Grindle S., Han X., Fermin D., Park S., Chen Y., Bache R.J., Mariash A., Guan Z., Ormaza S., Thompson J., Graziano J., et al. Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol. Genomics 2004, 17:283-291.
32. Han P., Hang C.T., Yang J., Chang C.P. Chromatin remodeling in cardiovascular development and physiology. Circ. Res. 2011, 108:378-396.
33. Hang C.T., Yang J., Han P., Cheng H.L., Shang C., Ashley E., Zhou B., Chang C.P. Chromatin regulation by Brg1 underlies heart muscle development and disease. Nature 2010, 466:62-67.
34. He A., Kong S.W., Ma Q., Pu W.T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. USA 2011, 108:5632-5637.
35. He A., Shen X., Ma Q., Cao J., von Gise A., Zhou P., Wang G., Marquez V.E., Orkin S.H., Pu W.T. PRC2 directly methylates GATA4 and represses its transcriptional activity. Genes Dev. 2012, 26:37-42.
36. Heineke J., Auger-Messier M., Xu J., Oka T., Sargent M.A., York A., Klevitsky R., Vaikunth S., Duncan S.A., Aronow B.J., Robbins J., Crombleholme T.M., et al. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J. Clin. Invest. 2007, 117:3198-3210.
37. Ho L., Crabtree G.R. Chromatin remodelling during development. Nature 2010, 463:474-484.
38. Holtzinger A., Rosenfeld G.E., Evans T. Gata4 directs development of cardiac-inducing endoderm from ES cells. Dev. Biol. 2010, 337:63-73.
39. Huang P., He Z., Ji S., Sun H., Xiang D., Liu C., Hu Y., Wang X., Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475:386-389.
40. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
41. Ikeda S., He A., Kong S.W., Lu J., Bejar R., Bodyak N., Lee K.H., Ma Q., Kang P.M., Golub T.R., Pu W.T. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell. Biol. 2009, 29:2193-2204.
42. Ismat F.A., Zhang M., Kook H., Huang B., Zhou R., Ferrari V.A., Epstein J.A., Patel V.V. Homeobox protein Hop functions in the adult cardiac conduction system. Circ. Res. 2005, 96:898-903.
43. Jay P.Y., Bielinska M., Erlich J.M., Mannisto S., Pu W.T., Heikinheimo M., Wilson D.B. Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects. Dev. Biol. 2007, 301:602-614.
44. Katz S.G., Williams A., Yang J., Fujiwara Y., Tsang A.P., Epstein J.A., Orkin S.H. Endothelial lineage-mediated loss of the GATA cofactor Friend of GATA 1 impairs cardiac development. Proc. Natl. Acad. Sci. USA 2003, 100:14030-14035.
45. Kim T.G., Chen J., Sadoshima J., Lee Y. Jumonji represses atrial natriuretic factor gene expression by inhibiting transcriptional activities of cardiac transcription factors. Mol. Cell. Biol. 2004, 24:10151-10160.
46. Kim Y., Phan D., van Rooij E., Wang D.Z., McAnally J., Qi X., Richardson J.A., Hill J.A., Bassel-Duby R., Olson E.N. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J. Clin. Invest. 2008, 118(1):124-132.
47. Kook H., Lepore J.J., Gitler A.D., Lu M.M., Wing-Man Yung W., Mackay J., Zhou R., Ferrari V., Gruber P., Epstein J.A. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 2003, 112:863-871.
48. Lee Y., Shioi T., Kasahara H., Jobe S.M., Wiese R.J., Markham B.E., Izumo S. The cardiac tissue-restricted homeobox protein Csx/Nkx2.5 physically associates with the zinc finger protein GATA4 and cooperatively activates atrial natriuretic factor gene expression. Mol. Cell. Biol. 1998, 18:3120-3129.
49. Li G., Margueron R., Ku M., Chambon P., Bernstein B.E., Reinberg D. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 2010, 24:368-380.
50. Liang Q., De Windt L.J., Witt S.A., Kimball T.R., Markham B.E., Molkentin J.D. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J. Biol. Chem. 2001, 276:30245-30253.
51. Liang Q., Wiese R.J., Bueno O.F., Dai Y.S., Markham B.E., Molkentin J.D. The transcription factor gata4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol. Cell. Biol. 2001, 21:7460-7469.
52. Lickert H., Takeuchi J.K., Von Both I., Walls J.R., McAuliffe F., Adamson S.L., Henkelman R.M., Wrana J.L., Rossant J., Bruneau B.G. Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 2004, 432:107-112.
53. Lin Q., Schwarz J., Bucana C., Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276:1404-1407.
54. Lin A.C., Roche A.E., Wilk J., Svensson E.C. The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. J. Biol. Chem. 2004, 279:55017-55023.
55. Linnemann A.K., O'Geen H., Keles S., Farnham P.J., Bresnick E.H. Genetic framework for GATA factor function in vascular biology. Proc. Natl. Acad. Sci. USA 2011, 108:13641-13646.
56. Lourenco D., Brauner R., Rybczynska M., Nihoul-Fekete C., McElreavey K., Bashamboo A. Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc. Natl. Acad. Sci. USA 2011, 108:1597-1602.
57. Lu J.R., McKinsey T.A., Xu H., Wang D.Z., Richardson J.A., Olsen E.N. FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors. Mol. Cell. Biol. 1999, 19:4495-4502.
58. Maitra M., Schluterman M.K., Nichols H.A., Richardson J.A., Lo C.W., Srivastava D., Garg V. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev. Biol. 2009, 326:368-377.
59. Manuylov N.L., Tevosian S.G. Cardiac expression of Tnnt1 requires the GATA4-FOG2 transcription complex. Sci. World J. 2009, 9:575-587.
60. Martin D.I., Orkin S.H. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev. 1990, 4:1886-1898.
61. McFadden D.G., Charite J., Richardson J.A., Srivastava D., Firulli A.B., Olson E.N. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. Development 2000, 127:5331-5341.
62. Merika M., Orkin S.H. DNA-binding specificity of GATA family transcription factors. Mol. Cell. Biol. 1993, 13:3999-4010.
63. Miyamoto S., Kawamura T., Morimoto T., Ono K., Wada H., Kawase Y., Matsumori A., Nishio R., Kita T., Hasegawa K. Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. Circulation 2006, 113:679-690.
64. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
65. Molkentin J.D. The zinc finger-containing transcription factors GATA-4, -5, and -6 Ubiquitously expressed regulators of tissue-specific gene expression. J. Biol. Chem. 2000, 275:38949-38952.
66. Morin S., Charron F., Robitaille L., Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 2000, 19:2046-2055.
67. Morin S., Paradis P., Aries A., Nemer M. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol. Cell. Biol. 2001, 21:1036-1044.
68. Morisco C., Seta K., Hardt S.E., Lee Y., Vatner S.F., Sadoshima J. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J. Biol. Chem. 2001, 276:28586-28597.
69. Morrisey E.E., Ip H.S., Lu M.M., Parmacek M.S. GATA-6: A zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev. Biol. 1996, 177:309-322.
70. Morrisey E.E., Ip H.S., Tang Z., Parmacek M.S. GATA-4 activates transcription via two novel domains that are conserved within the GATA-4/5/6 subfamily. J. Biol. Chem. 1997, 272:8515-8524.
71. Nadeau M., Georges R.O., Laforest B., Yamak A., Lefebvre C., Beauregard J., Paradis P., Bruneau B.G., Andelfinger G., Nemer M. An endocardial pathway involving Tbx5, Gata4, and Nos3 required for atrial septum formation. Proc. Natl. Acad. Sci. USA 2010, 107:19356-19361.
72. Narita N., Bielinska M., Wilson D.B. Wild-type endoderm abrogates the ventral developmental defects associated with GATA-4 deficiency in the mouse. Dev. Biol. 1997, 189:270-274.
73. Naya F.J., Black B.L., Wu H., Bassel-Duby R., Richardson J.A., Hill J.A., Olson E.N. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 2002, 8:1303-1309.
74. Nemer G., Fadlalah F., Usta J., Nemer M., Dbaibo G., Obeid M., Bitar F. A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum. Mutat. 2006, 27:293-294.
75. Newburger D.E., Bulyk M.L. UniPROBE: An online database of protein binding microarray data on protein-DNA interactions. Nucleic Acids Res. 2009, 37:D77-D82.
76. Niu Z., Yu W., Zhang S.X., Barron M., Belaguli N.S., Schneider M.D., Parmacek M., Nordheim A., Schwartz R.J. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J. Biol. Chem. 2005, 280:32531-32538.
77. Niu Z., Li A., Zhang S.X., Schwartz R.J. Serum response factor micromanaging cardiogenesis. Curr. Opin. Cell Biol. 2007, 19:618-627.
78. Oka T., Maillet M., Watt A.J., Schwartz R.J., Aronow B.J., Duncan S.A., Molkentin J.D. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ. Res. 2006, 98:837-845.
79. Omichinski J.G., Clore G.M., Schaad O., Felsenfeld G., Trainor C., Appella E., Stahl S.J., Gronenborn A.M. NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science 1993, 261:438-446.
80. Pal S., Cantor A.B., Johnson K.D., Moran T.B., Boyer M.E., Orkin S.H., Bresnick E.H. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc. Natl. Acad. Sci. USA 2004, 101:980-985.
81. Pasini D., Cloos P.A., Walfridsson J., Olsson L., Bukowski J.P., Johansen J.V., Bak M., Tommerup N., Rappsilber J., Helin K. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010, 464:306-310.
82. Peng T., Wang L., Zhou S.F., Li X. Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica 2010, 138:1231-1240.
83. Potthoff M.J., Olson E.N. MEF2: A central regulator of diverse developmental programs. Development 2007, 134:4131-4140.
84. Pu W.T., Ishiwata T., Juraszek A.L., Ma Q., Izumo S. GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev. Biol. 2004, 275:235-244.
85. Rajagopal S.K., Ma Q., Obler D., Shen J., Manichaikul A., Tomita-Mitchell A., Boardman K., Briggs C., Garg V., Srivastava D., Goldmuntz E., Broman K.W., et al. Spectrum of heart disease associated with murine and human GATA4 mutation. J. Mol. Cell. Cardiol. 2007, 43:677-685.
86. Rivera-Feliciano J., Lee K.H., Kong S.W., Rajagopal S., Ma Q., Springer Z., Izumo S., Tabin C.J., Pu W.T. Development of heart valves requires Gata4 expression in endothelial-derived cells. Development 2006, 133:3607-3618.
87. Roche A.E., Bassett B.J., Samant S.A., Hong W., Blobel G.A., Svensson E.C. The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex. J. Mol. Cell. Cardiol. 2008, 44:352-360.
88. Rojas A., De Val S., Heidt A.B., Xu S.M., Bristow J., Black B.L. Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development 2005, 132:3405-3417.
89. Rojas A., Kong S.W., Agarwal P., Gilliss B., Pu W.T., Black B.L. GATA4 is a direct transcriptional activator of Cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in anterior heart field-derived myocardium. Mol. Cell. Biol. 2008, 28:5420-5431.
90. Rojas A., Schachterle W., Xu S.M., Black B.L. An endoderm-specific transcriptional enhancer from the mouse Gata4 gene requires GATA and homeodomain protein-binding sites for function in vivo. Dev. Dyn. 2009, 238:2588-2598.
91. Rojas A., Schachterle W., Xu S.M., Martin F., Black B.L. Direct transcriptional regulation of Gata4 during early endoderm specification is controlled by FoxA2 binding to an intronic enhancer. Dev. Biol. 2010, 346:346-355.
92. Sakai Y., Nakagawa R., Sato R., Maeda M. Selection of DNA binding sites for human transcriptional regulator GATA-6. Biochem. Biophys. Res. Commun. 1998, 250:682-688.
93. Sepulveda J.L., Belaguli N., Nigam V., Chen C.Y., Nemer M., Schwartz R.J. GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: Role for regulating early cardiac gene expression. Mol. Cell. Biol. 1998, 18:3405-3415.
94. Sharma A., Masri J., Jo O.D., Bernath A., Martin J., Funk A., Gera J. Protein kinase C regulates internal initiation of translation of the GATA-4 mRNA following vasopressin-induced hypertrophy of cardiac myocytes. J. Biol. Chem. 2007, 282:9505-9516.
95. Shen X., Kim W., Fujiwara Y., Simon M.D., Liu Y., Mysliwiec M.R., Yuan G.C., Lee Y., Orkin S.H. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 2009, 139:1303-1314.
96. Shikama N., Lutz W., Kretzschmar R., Sauter N., Roth J.F., Marino S., Wittwer J., Scheidweiler A., Eckner R. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 2003, 22:5175-5185.
97. Shin C.H., Liu Z.P., Passier R., Zhang C.L., Wang D.Z., Harris T.M., Yamagishi H., Richardson J.A., Childs G., Olson E.N. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 2002, 110:725-735.
98. Srivastava D. Making or breaking the heart: From lineage determination to morphogenesis. Cell 2006, 126:1037-1048.
99. Svensson E.C., Huggins G.S., Lin H., Clendenin C., Jiang F., Tufts R., Dardik F.B., Leiden J.M. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat. Genet. 2000, 25:353-356.
100. Takaya T., Kawamura T., Morimoto T., Ono K., Kita T., Shimatsu A., Hasegawa K. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J. Biol. Chem. 2008, 283:9828-9835.
101. Takeuchi J.K., Bruneau B.G. Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors. Nature 2009, 459:708-711.
102. Takeuchi T., Watanabe Y., Takano-Shimizu T., Kondo S. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev. Dyn. 2006, 235:2449-2459.
103. Takeuchi J.K., Lou X., Alexander J.M., Sugizaki H., Delgado-Olguin P., Holloway A.K., Mori A.D., Wylie J.N., Munson C., Zhu Y., Zhou Y.Q., Yeh R.F., et al. Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat. Commun. 2011, 2:187.
104. Tevosian S.G., Deconinck A.E., Tanaka M., Schinke M., Litovsky S.H., Izumo S., Fujiwara Y., Orkin S.H. FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 2000, 101:729-739.
105. Tomita-Mitchell A., Maslen C.L., Morris C.D., Garg V., Goldmuntz E. GATA4 sequence variants in patients with congenital heart disease. J. Med. Genet. 2007, 44:779-783.
106. Tremblay J.J., Viger R.S. Transcription factor GATA-4 is activated by phosphorylation of serine 261 via the cAMP/protein kinase a signaling pathway in gonadal cells. J. Biol. Chem. 2003, 278:22128-22135.
107. Tremblay J.J., Hamel F., Viger R.S. Protein kinase A-dependent cooperation between GATA and CCAAT/enhancer-binding protein transcription factors regulates steroidogenic acute regulatory protein promoter activity. Endocrinology 2002, 143:3935-3945.
108. Trivedi C.M., Zhu W., Wang Q., Jia C., Kee H.J., Li L., Hannenhalli S., Epstein J.A. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev. Cell 2010, 19:450-459.
109. Tsai S.F., Martin D.I., Zon L.I., D'Andrea A.D., Wong G.G., Orkin S.H. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 1989, 339:446-451.
110. van Berlo J.H., Elrod J.W., van den Hoogenhof M.M., York A.J., Aronow B.J., Duncan S.A., Molkentin J.D. The transcription factor GATA-6 regulates pathological cardiac hypertrophy. Circ. Res. 2010, 107:1032-1040.
111. van Berlo J.H., Elrod J.W., Aronow B.J., Pu W.T., Molkentin J.D. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 2011, 108:12331-12336.
112. Visel A., Blow M.J., Li Z., Zhang T., Akiyama J.A., Holt A., Plajzer-Frick I., Shoukry M., Wright C., Chen F., Afzal V., Ren B., et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009, 457:854-858.
113. Wang J., Feng X.H., Schwartz R.J. SUMO-1 modification activated GATA4-dependent cardiogenic gene activity. J. Biol. Chem. 2004, 279:49091-49098.
114. Watt A.J., Battle M.A., Li J., Duncan S.A. GATA4 is essential for formation of the proepicardium and regulates cardiogenesis. Proc. Natl. Acad. Sci. USA 2004, 101:12573-12578.
115. Wei J.Q., Shehadeh L.A., Mitrani J.M., Pessanha M., Slepak T.I., Webster K.A., Bishopric N.H. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 2008, 118:934-946.
116. Xin M., Davis C.A., Molkentin J.D., Lien C.L., Duncan S.A., Richardson J.A., Olson E.N. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. USA 2006, 103:11189-11194.
117. Yanazume T., Hasegawa K., Morimoto T., Kawamura T., Wada H., Matsumori A., Kawase Y., Hirai M., Kita T. Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell. Biol. 2003, 23:3593-3606.
118. Yang H.Y., Evans T. Distinct roles for the two cGATA-1 finger domains. Mol. Cell. Biol. 1992, 12:4562-4570.
119. Yao T.P., Oh S.P., Fuchs M., Zhou N.D., Ch'ng L.E., Newsome D., Bronson R.T., Li E., Livingston D.M., Eckner R. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998, 93:361-372.
120. Yu M., Riva L., Xie H., Schindler Y., Moran T.B., Cheng Y., Yu D., Hardison R., Weiss M.J., Orkin S.H., Bernstein B.E., Fraenkel E., et al. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell 2009, 36:682-695.
121. Zaret K.S., Watts J., Xu J., Wandzioch E., Smale S.T., Sekiya T. Pioneer factors, genetic competence, and inductive signaling: Programming liver and pancreas progenitors from the endoderm. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:119-126.
122. Zeisberg E.M., Ma Q., Juraszek A.L., Moses K., Schwartz R.J., Izumo S., Pu W.T. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 2005, 115:1522-1531.
123. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110:479-488.
124. Zhang W., Li X., Shen A., Jiao W., Guan X., Li Z. GATA4 mutations in 486 Chinese patients with congenital heart disease. Eur. J. Med. Genet. 2008, 51:527-535.
125. Zhang W.M., Li X.F., Ma Z.Y., Zhang J., Zhou S.H., Li T., Shi L., Li Z.Z. GATA4 and NKX2.5 gene analysis in Chinese Uygur patients with congenital heart disease. Chin. Med. J. (Engl.) 2009, 122:416-419.
126. Zhao R., Watt A.J., Battle M.A., Li J., Bondow B.J., Duncan S.A. Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev. Biol. 2008, 317:614-619.
127. Zhou B., Ma Q., Kong S.W., Hu Y., Campbell P.H., McGowan F.X., Ackerman K.G., Wu B., Zhou B., Tevosian S.G., Pu W.T. Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart. J. Clin. Invest. 2009, 119:1462-1476.